Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis.
Exp Hematol Oncol
; 9: 6, 2020.
Article
in En
| MEDLINE
| ID: mdl-32322437
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Systematic_reviews
Language:
En
Journal:
Exp Hematol Oncol
Year:
2020
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
United kingdom